International Shooting Sport Federation
ISSF
NEWS
CALENDAR
General Assembly
Competitions
ATHLETES
Inside ISSF
Rules
Inside ISSF
Home
Inside ISSF
Anti-Doping
Information Portal on Doping - IPOD
Anti-Doping and Clean Sport
Therapeutic Use Exemption
Information Portal on Doping - IPOD
News
FAQ
ISSF Outreach Posters
Education and Awareness
WADA
2021 World Anti Doping Code
ADAMS
International Standards
2024 Prohibited List
2024 Summary
2024 Monitoring Program
IPOD Articles
Articles 2024
1.
2024-IPOD-2-Prohibited-List-2025.pdf
2.
2024-IPOD-1-OG-edition.pdf
Articles 2023
1.
2023-IPOD-5-2023-Year-End-Report.pdf
2.
2023-IPOD-4-Prohibited-List.pdf
3.
2023-IPOD-3-Reminders-about-the-risks-associated-with-supplement-use.pdf
4.
2023-IPOD-2_2022-Year-End-Report.pdf
5.
2023-IPOD-1st-Edition-2023-ADEL-Resources.pdf
Articles 2022
1.
2022_IPOD-6_WADA-Prohibited-List-2023.pdf
2.
2022_IPOD-5_Education-on-Privacy-and-Information-Security-Awareness.pdf
3.
2022_IPOD-4_Reminders-about-the-risks-associated-with-supplement-use.pdf
4.
2022_IPOD-3_Webinar-for-athletes-on-the-List-and-TUEs.pdf
5.
2022_IPOD-2_Key-areas-of-athlete-vulnerabilities-to-doping.pdf
6.
2022_IPOD-1_2021-Year-End-Report.pdf
Articles 2021
1.
2021_IPOD-3_2022-Prohibited-List.pdf
2.
2021_IPOD-2_Important-anti-doping-reminders-before-Tokyo-OGs.pdf
3.
2021_IPOD-1_2020-Year-End-Report.pdf
Articles 2020
1.
2020_IPOD-3_2021-Prohibited-List.pdf
2.
2020_IPOD-2_Notice-on-revised-ISSF-Anti-Doping-Rules-coming-into-effect-January-1-2021.pdf
3.
2020_IPOD-1_2019-Year-End-Report.pdf
Articles 2019
1.
2019_IPOD-6_2020-Prohibited-List.pdf
2.
2019_IPOD-5_Reminders-to-Athletes-on-risks-of-taking-supplements.pdf
3.
2019_IPOD-4_Reminders-to-Verify-Medication.pdf
4.
2019_IPOD-3_Roles-Responsibilities-and-Duties-of-all-ISSF-Athletes.pdf
5.
2019_IPOD-2_Therapeutic-Use-Exemptions.pdf
6.
2019_IPOD-1_Risks-of-supplement-use-and-Inadvertent-doping.pdf
Articles 2018
1.
2018_IPOD-6_Youth-Olympic-Games-ISSF-Focus-Day.pdf
2.
2018_IPOD-5_Testing-at-the-Changwon-World-Championships.pdf
3.
2018_IPOD-4_Focus-on-the-WADA-Athletes-Committee.pdf
4.
2018_IPOD-3_ADEL-the-new-Anti-Doping-E-Learning-Platform.pdf
5.
2018_IPOD-2_Monitoring-Compliance-to-the-ISSF-Anti-Doping-Rules-and-the-World-Anti-Doping-Code.pdf
6.
2018_IPOD-1_2017-Anti-Doping-Report-and-Looking-Ahead-to-2018.pdf
Articles 2017
1.
2017_IPOD-6_The-ISSF-Anti-Doping-Committee-and-Code-Compliance.pdf
2.
2017_IPOD-5_An-Ongoing-Debate.pdf
3.
2017_IPOD-4_Speaking-Out-on-Doping.pdf
4.
2017_IPOD-3_ISSF-Compliance-with-the-World-Anti-Doping-Code.pdf
5.
2017_IPOD-2_Test-Your-Anti-Doping-Knowledge.pdf
6.
2017_IPOD-1_2016-Anti-Doping-Report-and-Looking-Ahead-to-2017.pdf
Articles 2016
1.
2016_IPOD-6_Privacy-Issues-in-Anti-Doping.pdf
2.
2016_IPOD-4_Take-the-Anti-Doping-Quiz.pdf
3.
2016_IPOD-3_The-IPOD-answers-questions-on-Meldonium-and-Jurisdiction-over-Athletes-at-the-OGs.pdf
4.
2016_IPOD-2_Education-and-Awareness-Successful-Anti-Doping-Programs.pdf
5.
2016_IPOD-1_2015-Anti-Doping-Report-and-Looking-ahead-to-2016.pdf
Articles 2015
1.
2015_IPOD-6_Prohibited-Association-Explained.pdf
2.
2015_IPOD-5_Substantial-Assistance-Explained.pdf
3.
2015_IPOD-4_Interview-with-ISSF-Athletes-Committee-Chairman-Abhinav-Bindra.pdf
4.
2015_IPOD-3_The-WADA-ADO-Symposium-Intelligence-Based-Testing-The-ISSF-RTP.pdf
5.
2015_IPOD-2_The-IPOD-answers-questions-on-Supplements-Use-and-TUEs.pdf
6.
2015_IPOD-1_2014-Anti-Doping-Report-and-looking-ahead-to-2015.pdf
Articles 2014
1.
2014_IPOD-6_The-2015-ISSF-Anti-Doping-Rules.pdf
2.
2014_IPOD-5_Therapeutic-Use-Exemptions-Process.pdf
3.
2014_IPOD-4_A-New-and-Revised-World-Anti-Doping-Code.-Part-III.pdf
4.
2014_IPOD-3_A-New-and-Revised-World-Anti-Doping-Code.-Part-II.pdf
5.
2014_IPOD-2_A-New-and-Revised-World-Anti-Doping-Code.-Part-I.pdf
6.
2014_IPOD-1_2013-Anti-Doping-Report.pdf
Articles 2013
1.
2013_IPOD-6_Looking-head-to-2014.pdf
2.
2013_IPOD-5_The-IPOD-answers-3-questions-from-its-readers.pdf
3.
2013_IPOD-4_The-IPOD-answers-6-questions-from-its-readers.pdf
4.
2013_IPOD-3_ISSFs-Role-in-Anti-Doping-Education-and-Prevention.pdf
5.
2013_IPOD-2_WADA-Accredited-Laboratories-for-Doping-Control-Analysis.pdf
6.
2013_IPOD-1_2012-Anti-Doping-Report-and-looking-ahead-to-2013.pdf
Articles 2012
1.
2012_IPOD-5_2013-Prohibited-List.pdf
2.
2012_IPOD-4_Anti-Doping-at-the-2012-Summer-Olympic-Games-in-London.pdf
3.
2012_IPOD-3_Focus-on-Regional-Anti-Doping-Organisations-RADOs.pdf
4.
2012_IPOD-2_World-Anti-Doping-Code-review-process-and-Risks-of-Supplements.pdf
5.
2012_IPOD-1_2011-Anti-Doping-Report.pdf
Articles 2011
1.
2011_IPOD-6_2012-Prohibited-List.pdf
2.
2011_IPOD-5_Supplements-Risks-vs-Rewards.pdf
3.
2011_IPOD-4_The-IPOD-answers-3-questions-from-its-readers.pdf
4.
2011_IPOD-3_The-IPOD-answers-2-questions-from-its-readers.pdf
5.
2011_IPOD-2_The-IPOD-answers-3-questions-from-its-readers.pdf
6.
2011_IPOD-1_2010-Anti-Doping-Report.pdf
Articles 2010
1.
2010_IPOD-6_Looking-ahead-to-ISSFs-Anti-Doping-Initiatives-for-2011.pdf
2.
2010_IPOD-5_Focus-on-the-ISSF-Medical-Committee.pdf
3.
2010_IPOD-4_The-Importance-of-Anti-Doping-Education.pdf
4.
2010_IPOD-3_Focus-on-WADA-the-World-Anti-Doping-Agency.pdf
5.
2010_IPOD-2_The-WADA-Prohibited-List.pdf
6.
2010_IPOD-1_2009-Anti-Doping-Report.pdf
Articles 2009
1.
2009_IPOD-6_The-IOC-Medical-Commission-and-WADA.pdf
2.
2009_IPOD-5_Beware-of-Beta-Blockers.pdf
3.
2009_IPOD-4_Abbreviated-Therapeutic-Use-Exemptions.pdf
4.
2009_IPOD-3_Q-A-on-Therapeutic-Use-Exemptions.pdf
5.
2009_IPOD-2_Q-A-on-Prohibited-Substances-the-IPOD-quiz.pdf